hemophilia a patients receiving factor viii concentrate as replacement therapy had the most pronounced changes including decreased t4/t8 ratios and lower in vitro responsiveness to both phytohemagglutinin and pokeweed mitogen .
C0019069
hemophilia a
C0015506
factor viii